- Business Wire•9 months ago
As previously reported, NovaDel Pharma Inc. sold its ZolpiMist® assets to Amherst Pharmaceuticals, Inc. principally in exchange for the assumption of Novadel’s FDA liabilities of approximately $2.2 million.
We're sorry this is all we were able to find about this topic.
Novadel Pharma Inc. (NVDL)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.68|
|Avg Vol (3m)||20,636|
|Dividend & Yield||N/A (N/A)|